Neuprex BPI-derived agent: Phase III Update

Xoma Corp. (XOMA), Berkeley,

Read the full 44 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE